Zydus生命科学公司从Temasek的完美日公司获得Sterling生物技术50%的股份,组成了50:50的无动物蛋白质生产合资企业。 Zydus Lifesciences acquires a 50% stake in Sterling Biotech from Temasek's Perfect Day Inc, forming a 50:50 joint venture for animal-free protein production.
印度制药公司Zydus Lifesciences从Temasek投资组合公司Perfect Day Inc.获得了斯特林生物技术的50%股权. Indian pharma firm Zydus Lifesciences acquires a 50% stake in Sterling Biotech from Perfect Day Inc, a Temasek portfolio company. 收购创建了一个50:50的合资企业,董事会具有平等的代表权。 The acquisition creates a 50:50 joint venture with equal board representation. 合资企业将建立一个制造设施,生产发酵的无动物蛋白质,对象是健康和营养消费者,他们更喜欢无动物蛋白或乳糖不耐受性。 The joint venture will establish a manufacturing facility to produce fermented animal-free protein, targeting health and nutrition consumers who prefer animal-free protein or have lactose intolerance. 完美日精密发酵蛋白质用于各种产品,包括冰淇淋、奶油奶酪、运动营养和烘烤品,其功能效益较高,环境影响较低。 Perfect Day's precision-fermented protein is used in various products, including ice creams, cream cheese, sports nutrition, and baked goods, with high functionality benefits and lower environmental impact.